Digicomply is now part of SGS Food Nexus  Learn more →
Food Safety Incidents

Unapproved therapeutic claims has been detected in Food Supplement Variety.

March 31 2026

Explore Regulations & Risks

Incident Report: Unapproved Therapeutic Claims in Food Supplement

Articles in this database are automatically generated by our AI system based on data from the Digicomply APP. While we strive for accuracy, the articles may not contain complete or verified information and are intended for informational purposes only. For accurate and reliable information, we recommend using SGS Digicomply or consulting verified sources and experts. All content is copyrighted; please credit SGS Digicomply (digicomply.com) when sharing.

Incident Report: Unapproved Therapeutic Claims in Food Supplement

On March 19, 2026, a significant food safety incident was reported involving a food supplement variety originating from Brazil. The Brazilian Health Regulatory Agency, known as ANVISA, identified that this product contained unapproved therapeutic claims, raising concerns regarding its safety and compliance with regulatory standards.

Food supplements are intended to provide nutritional support and should not make health claims that have not been substantiated through rigorous scientific evidence. The presence of unapproved claims can mislead consumers regarding the efficacy and safety of the product, potentially leading to misuse or over-reliance on the supplement for health benefits.

Regulatory agencies play a crucial role in ensuring that food products, including dietary supplements, adhere to established safety guidelines. The detection of such claims necessitates immediate action to protect consumers, which may include product recalls, public advisories, and further investigations into the manufacturing processes of the implicated food supplement.

Consumers are advised to remain vigilant and consult with healthcare professionals before using any food supplements, especially those that make health claims. It is essential to prioritize safety and ensure that products consumed meet the necessary regulatory standards.


  • Incident: Unapproved therapeutic claims has been detected in Food Supplement Variety.
  • Date: 2026-03-19
  • Product: Food Supplement Variety
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA

For more detailed information about this and other similar incidents, with access to filtering options, historical data, and trend analysis, try the SGS Digicomply Food Safety Software. Explore SGS Digicomply Food Safety Intelligence Hub demos here. (for enterprises only, no individual plans)

Tags: March 2026